Statistics for Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and its Specific Treatment with Alirocumab, a PCSK9 Monoclonal Antibody
Total visits
| views | |
|---|---|
| Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and its Specific Treatment with Alirocumab, a PCSK9 Monoclonal Antibody | 71 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
File Visits
| views | |
|---|---|
| Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 50 |
| France | 6 |
| Germany | 5 |
| Portugal | 5 |
| China | 3 |
| Canada | 1 |
| Russia | 1 |